Log In
Print
BCIQ
Print
Print this Print this
 

iCo-007

Also known as: formerly ISIS 13650

  Manage Alerts
Collapse Summary General Information
Company Isis Pharmaceuticals Inc.
DescriptionSecond-generation antisense inhibitor of c-raf kinase
Molecular Target c-raf mRNA
Mechanism of ActionAntisense therapy
Therapeutic ModalityNucleic acid: Linear RNA: Antisense

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today